PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers.
PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers.
复制标题
PI3K/AKT通路是调控肿瘤多药耐药的关键环节。
DOI:
10.1038/s41419-020-02998-6
复制
发表时间:
2020-09-24
影响因子:
9
通讯作者:
Liu Y
中科院分区:
文献类型:
--
作者:
Liu R;Chen Y;Liu G;Li C;Song Y;Cao Z;Li W;Hu J;Lu C;Liu Y
Multidrug resistance (MDR) is the dominant challenge in the failure of chemotherapy in cancers. Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase that spreads intracellular signal cascades and regulates a variety of cellular processes. PI3Ks are considered significant causes of chemoresistance in cancer therapy. Protein kinase B (AKT) is also a significant downstream effecter of PI3K signaling, and it modulates several pathways, including inhibition of apoptosis, stimulation of cell growth, and modulation of cellular metabolism. This review highlights the aberrant activation of PI3K/AKT as a key link that modulates MDR. We summarize the regulation of numerous major targets correlated with the PI3K/AKT pathway, which is further related to MDR, including the expression of apoptosis-related protein, ABC transport and glycogen synthase kinase-3 beta (GSK-3β), synergism with nuclear factor kappa beta (NF-κB) and mammalian target of rapamycin (mTOR), and the regulation of glycolysis.
登录
查看更多内容
影响因子:
12.4
作者:
Adams JM;Cory S
通讯作者:
Cory S
DOI:
10.1159/000496040
发表时间:
2018-01-01
期刊:
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
影响因子:
--
作者:
Dai, Yuxin;Wan, Yongkun;Ou, Jingmin
通讯作者:
Ou, Jingmin
影响因子:
8.2
作者:
Deng, Lan;Jiang, Ling;Wang, Xiu-Ju
通讯作者:
Wang, Xiu-Ju
影响因子:
7.2
作者:
Cai, Hong;Li, Liangjun;Yang, Chunhui
通讯作者:
Yang, Chunhui
DOI:
10.12703/p7-13
发表时间:
2015
期刊:
F1000prime reports
影响因子:
--
作者:
Brown KK;Toker A
通讯作者:
Toker A